21484 ⎘
Preparations for testing; Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier; Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being cyclic, e.g. DOTA the metal complex being Gd-DOTA
PROCESS FOR PRODUCING A CONTRAST AGENT
#2GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES
#3GENERATION OF SYNTHETIC RADIOLOGICAL IMAGES
#4CONTRAST AGENTS FOR USE IN DIAGNOSTIC COMPUTED TOMOGRAPHY IMAGING
#5COMBINATIONS OF CONTRAST AGENTS
#6GENERATING SYNTHETIC REPRESENTATIONS
#7TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
#8METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#9GENERATING SYNTHETIC REPRESENTATIONS
#10FORMULATION OF CONTRAST MEDIA AND PROCESS OF PREPARATION THEREOF
#11Perfluorocarbon-Containing Contrast Agent for Use in MRI Imaging of Body Cavities
#12MRI-AGENT LOADED PLATELET COMPOSITIONS AND METHODS OF PREPARING AND USING THE SAME
#13DETECTION OF ARTIFACTS IN SYNTHETIC IMAGES
#14LANTHANIDE-BASED CONTRAST AGENTS HAVING IMPROVED STABILITY AND METHODS FOR THEIR PRODUCTION AND PURIFICATION
#15GENERATION OF ARTIFICIAL CONTRAST-ENHANCED RADIOLOGICAL IMAGES
#16GADOLINIUM-BASED COMPOUND AND MRI CONTRAST AGENT COMPRISING SAME
#17LANTHANIDE COMPLEX FORMULATIONS
#18GADOLINIUM BEARING PCTA-BASED CONTRAST AGENTS
#19LANTHANIDE COMPLEX FORMULATIONS
#20MOLECULAR PROBES FOR IN VIVO DETECTION OF ALDEHYDES
#21FLUORESCENCE-MAGNETIC RESONANCE DUAL-MODALITY CONTRAST AGENT, PREPARATION METHOD THEREFOR AND USE THEREOF
#22Formulation of contrast media and process of preparation thereof
#23METASTABLE-FREE LANTHANIDE BASED CONTRAST AGENTS AND METHOD
#24PLASTIC CONTAINERS
#25FIBROBLAST ACTIVATION PROTEIN-TARGETED MAGNETIC RESONANCE IMAGING AGENTS, COMPOSITIONS, AND METHODS OF USE
#26TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#27Bismuth-Gadolinium Nanoparticles
#28PROCEDURE FOR OBTAINING GADOTERATE MEGLUMINE FROM HIGH-PURITY TETRAXETAN (DOTA) AND ITS USE IN THE PREPARATION OF INJECTABLE GALENICAL FORMULATIONS
#29NOVEL GADOLINIUM-BASED COMPOUND, METHOD FOR PRODUCING SAME, AND MRI CONTRAST AGENT CONTAINING SAME
#30Polydopamine decorated tobacco mosaic theranostic virus nanoparticles
#31MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY
#32NOVEL GADOLINIUM-BASED COMPOUND, PREPARATION METHOD THEREFOR, AND MRI CONTRAST AGENT CONTAINING SAME
#33NOVEL MANUFACTURING PROCESS FOR GADOLINIUM COMPLEXES
#34REDUCED METASTABLE COMPLEX MACROCYCLIC CONTRAST AGENTS
#35NOVEL GADOLINIUM-BASED COMPOUND, METHOD FOR PRODUCING SAME, AND MRI CONTRAST AGENT CONTAINING SAME
#36PHARMACEUTICAL COMPOSITIONS OF GD-BASED CONTRAST AGENTS
#37Lanthanide complex formulations
#38Targeted contrast agents for MRI of alpha-synuclein deposition
#39Coated plant virus imaging agents
#40IMAGING WITH LIPOSOME-BASED CONTRAST AGENTS BASED ON MODULATION OF MEMBRANE WATER PERMEABILITY
#41SOLVENT FREE GADOLINIUM CONTRAST AGENTS
#42HEPARANASE COMPOUNDS AND METHODS OF USE
#43METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#44Reduced metastable complex macrocyclic contrast agents
#45METHOD FOR TREATING CANCER WITH KIDNEY PROTECTION
#46Pharmaceutical compositions comprising Gd-complexes and polyarylene additives
#47TARGETED CONTRAST AGENTS FOR MRI OF AMYLOID DEPOSITION
#48Formulation of contrast media and process of preparation thereof
#49TARGETED CONTRAST AGENTS FOR MRI OF ALPHA-SYNUCLEIN DEPOSITION
#50Polydopamine decorated tobacco mosaic theranostic virus nanoparticles
#51Targeted contrast agents for MRI of amyloid deposition
#52Gadolinium bearing PCTA-based contrast agents
#53METHODS AND AGENTS FOR THE DETECTION AND TREATMENT OF CANCER
#54Plastic containers
#55Compound, antiinflammatory drug comprising the compound and cyclooxygenase-2 inhibitor comprising the compound
#56Dimeric contrast agents
#57MAGNETIC RESONANCE IMAGING (MRI) CONTRAST AGENTS AND USE THEREOF
#58PREPARATION METHOD OF INTERMEDIATE OF GADOLINIUM-BASED IONIC CONTRAST AGENT AND USE THEREOF
#59PROCESS FOR PRODUCING A CONTRAST AGENT
#60Coated plant virus imaging agents
#61DIMERIC CONTRAST AGENTS
#62Contrast agents
#63METAL/RADIOMETAL-LABELED PSMA INHIBITORS FOR PSMA-TARGETED IMAGING AND RADIOTHERAPY
#64Development of injectable fiducial markers for image guided radiotherapy with dual MRI and CT visibility
#65Gadobutrol intermediate and gadobutrol production method using same
#66Lanthanide complex formulations
#67Ultrafine nanoparticles as multimodal contrast agent
#68Metal-organic frameworks for the adsorption and catalytic transformations of carbon dioxide
#69MODIFIED MRI CONTRAST AGENTS AND USES THEREOF
#70Dimeric contrast agents
#71Bismuth-gadolinium nanoparticles
#72Solvent-free gadolinium contrast agents
#73Dimeric contrast agents
#74POLYMALIC ACID BASED NANOCONJUGATES FOR IMAGING
#75TARGETED DRUG DELIVERY AND THERAPEUTIC METHODS USING APO-E MODIFIED LIPID NANOPARTICLES
#76Gadolinium complex, method for synthesis of the gadolinium complex, and MRI contrast agent including the gadolinium complex
#77SOLVENT-FREE GADOLINIUM CONTRAST AGENTS
#78CEST systems exhibiting a concentration independent responsiveness
#79Gadolinium-based contrast agents for sensitive detection of Znwith MRI
#80Process for preparation of beads for imaging
#81PAMAM dendrimer based CEST imaging agents and uses thereof
#82Non-nutritive sweeteners and polyols as imaging agents
#83Dimeric contrast agents
#84Contrast agents
#85Combination formulation
#86Coated plant virus imaging agents
#87NEURODEGENERATIVE DISORDERS
#88Plastic containers
#89Solvent-Free Gadolinium Contrast Agents
#90Targeted contrast agents comprising a hydrazide functional group
#91Metal complex formulations
#92Lanthanide complex formulations
#93Formulations of metal complexes
#94Modular Imaging Agents Containing Amino Acids and Peptides
#95Method for producing a liquid pharmaceutical preparation
#96Method and compositions for orally administered contrast agents for MR imaging
#97Process for preparing a pharmaceutical formulation of contrast agents
#98Gadolinium-based contrast agents for sensitive detection of Znwith MRI
#99Metal/radiometal-labeled PSMA inhibitors for PSMA-targeted imaging and radiotherapy
#100Graphene oxide mediated cellular delivery of gadolinium-labeled molecules
#101Metal Chelate Compounds for Binding to the Platelet Specific Glycoprotein IIb/IIIa
#102Process for purifying 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetraacetic acid
#103Camelid single-domain antibody directed against amyloid beta and methods for producing conjugates thereof
#104Gadolinium complex comprising DO3A-tranexamic acid conjugate
#105CATIONIC CONTRAST AGENTS AND METHODS OF USING THE SAME
#106System and method for quantitative magnetic resonance (MR) analysis using T1 mapping
#107Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form
#108PROCESS FOR PREPARING A PHARMACEUTICAL FORMULATION OF CONTRAST AGENTS
#109Process for preparing a pharmaceutical formulation of contrast agents
#110CANCER CELL SPECIFIC IMAGING PROBES AND METHODS OF USE
#111Multimeric dual-modality breast cancer diagnostic agents
#112Contrast medium formulation and related preparation method
#113PROCESS FOR PRODUCING A COMPLEX OF A LANTHANIDE WITH A MACROCYCLIC LIGAND
#114Coated plant virus imaging agents
#115PORPHYRAZINE OPTICAL AND DUAL OPTICAL/ MR CONTRAST AND THERAPEUTIC AGENTS
#116Process for producing 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid and complexes thereof
#117PEPTIDIC STRUCTURES INCORPORATING AN AMINO ACID METAL COMPLEX AND APPLICATIONS IN MAGNETIC RESONANCE IMAGING
#118Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
#119Ultrafine nanoparticles as multimodal contrast agent
#120Modular imaging agents containing amino acids and peptides
#121Molecular design toward dual-modality probes for radioisotope-based imaging (PET or SPECT) and MRI
#122Composition comprising acetic anhydride and a gadolinium complex, and method for the use in hyperpolarisation in MRI analysis
#123Multimeric biotinidase resistant multimodality probes
#124Multimeric dual-modality breast cancer diagnostic agents
#125CONTAINER WITH CONCENTRATED SUBSTANCE AND METHOD OF USING THE SAME
#126TARGETED CONTRAST AGENTS AND USES THEREOF
#127Multimeric peptidomimetic fibrosis specific dual-modality probes
#128MRI contrast agents
#129In Vivo Mitochondrial Labeling Using Positively-CHarged Nitroxide Enhanced and Gadolinum Chelate Enhanced Magnetic Resonance Imaging
#130Lanthanoid complex capsule and particle contrast agents, methods of making and using thereof
#131Method for preparing a pharmaceutical formulation of lanthanide chelate in powder form
#132Process for preparing a pharmaceutical formulation of contrast agents
#133In vivo mitochondrial labeling using positively-charged nitroxide enhanced and gadolinium chelate enhanced magnetic resonance imaging
#134Process for preparing a pharmaceutical formulation of contrast agents